Towa Pharmaceutical Co., Ltd. logo

Towa Pharmaceutical Co., Ltd. (6QC)

Market Open
11 Aug, 06:03
XFRA XFRA
19. 70
-0.2
-1.005%
971.87M Market Cap
- P/E Ratio
80% Div Yield
200 Volume
- Eps
19.9
Previous Close
Add Transaction
Day Range
19.7 19.7
Year Range
15.2 23.6
Want to track 6QC and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Name Time Cons. EPS Eps
Towa Pharmaceutical Co., Ltd. logo
6QC Towa Pharmaceutical Co., Ltd.
7 May 2026
113.89
-
Towa Pharmaceutical Co., Ltd. logo
6QC Towa Pharmaceutical Co., Ltd.
5 Feb 2026
57.66
-
Towa Pharmaceutical Co., Ltd. logo
6QC Towa Pharmaceutical Co., Ltd.
10 Nov 2025
49.62
-
Towa Pharmaceutical Co., Ltd. logo
6QC Towa Pharmaceutical Co., Ltd.
6 Aug 2025
-
-
Towa Pharmaceutical Co., Ltd. logo
6QC Towa Pharmaceutical Co., Ltd.
12 May 2025
-
-
Towa Pharmaceutical Co., Ltd. logo
6QC Towa Pharmaceutical Co., Ltd.
8 Aug 2024
-
-
Towa Pharmaceutical Co., Ltd. logo
6QC Towa Pharmaceutical Co., Ltd.
14 May 2024
-
-

6QC Earnings Reports FAQ

What is the earnings per share (EPS) for 6QC?

EPS data for 6QC is currently not available, as Towa Pharmaceutical Co., Ltd has not reported recent earnings.

What is the company's earnings growth rate?

Towa Pharmaceutical Co., Ltd has not announced its next earnings release date. You can monitor upcoming announcements in Marketlog's earnings calendar or in the company profile.

When is the next earnings release date?

Towa Pharmaceutical Co., Ltd has not announced its next earnings release date.

What were the most recent quarterly earnings?

The most recent quarterly earnings for Towa Pharmaceutical Co., Ltd are not available at this time.

What is the price-to-earnings (P/E) ratio?

There is no P/E ratio for 6QC at this time, as Towa Pharmaceutical Co., Ltd has no recent EPS data to calculate it.